BACKGROUND: Clinical trials of microbicides should include adolescent participants. There may be unique challenges including obtaining informed consent, meeting eligibility criteria and adherence to study demands. We report on our experience enrolling young adolescents in a microbicide surrogate acceptability study and the implication of our experience for other types of clinical trials. METHODS: Adolescent females were enrolled in a microbicide surrogate acceptability study for 6 months which required parental consent. They were asked to use the product every time they had coitus. They had face-to-face interviews at intake, 3 and 6 months, and completed weekly phone diaries. RESULTS: Of the 208 enrolled, 95 participants were between 14 and 17 years. Ten were pregnant at intake, and 15 did not have sex during the study. Of the remaining 70 adolescents, 46 (66%) used the product at least once during the 6-month period, and all but seven attended a face-to-face interview after intake. CONCLUSIONS: It will be possible to include young adolescents in clinical studies, even if parental consent is required. However, there will be challenges, and researchers need to anticipate those challenges and reduce barriers to enrolling young adolescents.
BACKGROUND: Clinical trials of microbicides should include adolescent participants. There may be unique challenges including obtaining informed consent, meeting eligibility criteria and adherence to study demands. We report on our experience enrolling young adolescents in a microbicide surrogate acceptability study and the implication of our experience for other types of clinical trials. METHODS: Adolescent females were enrolled in a microbicide surrogate acceptability study for 6 months which required parental consent. They were asked to use the product every time they had coitus. They had face-to-face interviews at intake, 3 and 6 months, and completed weekly phone diaries. RESULTS: Of the 208 enrolled, 95 participants were between 14 and 17 years. Ten were pregnant at intake, and 15 did not have sex during the study. Of the remaining 70 adolescents, 46 (66%) used the product at least once during the 6-month period, and all but seven attended a face-to-face interview after intake. CONCLUSIONS: It will be possible to include young adolescents in clinical studies, even if parental consent is required. However, there will be challenges, and researchers need to anticipate those challenges and reduce barriers to enrolling young adolescents.
Authors: Peter H Kilmarx; Janneke H H M van de Wijgert; Supaporn Chaikummao; Heidi E Jones; Khanchit Limpakarnjanarat; Barbara A Friedland; John M Karon; Chomnad Manopaiboon; Nucharee Srivirojana; Somboonsak Yanpaisarn; Somsak Supawitkul; Nancy L Young; Philip A Mock; Kelly Blanchard; Timothy D Mastro Journal: J Acquir Immune Defic Syndr Date: 2006-11-01 Impact factor: 3.731
Authors: Kathleen Morrow; Rochelle Rosen; Linda Richter; Anne Emans; Anna Forbes; Jennifer Day; Neetha Morar; Lisa Maslankowski; Albert T Profy; Cliff Kelly; Salim S Abdool Karim; Kenneth H Mayer Journal: J Womens Health (Larchmt) Date: 2003-09 Impact factor: 2.681
Authors: D'Nyce L Williams; Daniel R Newman; Susan A Ballagh; Mitchell D Creinin; Kurt Barnhart; Debra H Weiner; April J Bell; Denise J Jamieson Journal: Sex Transm Dis Date: 2007-12 Impact factor: 2.830
Authors: Amelia S Knopf; Amy Lewis Gilbert; Gregory D Zimet; Bill G Kapogiannis; Sybil G Hosek; J Dennis Fortenberry; Mary A Ott Journal: AJOB Empir Bioeth Date: 2016-10-21
Authors: Lily F Hoffman; Neferterneken K Francis; Marina Catallozzi; Jenny K R Francis; Lawrence R Stanberry; Susan L Rosenthal Journal: J Adolesc Health Date: 2016-03-12 Impact factor: 5.012
Authors: Marina Catallozzi; Ariel M de Roche; Mei-Chen Hu; Carmen Radecki Breitkopf; Jane Chang; Lisa S Ipp; Jenny K R Francis; Susan L Rosenthal Journal: J Pediatr Adolesc Gynecol Date: 2016-07-02 Impact factor: 1.814
Authors: Charlene S Dezzutti; Elizabeth R Brown; Bernard Moncla; Julie Russo; Marilyn Cost; Lin Wang; Kevin Uranker; Ratiya P Kunjara Na Ayudhya; Kara Pryke; Jim Pickett; Marc-André Leblanc; Lisa C Rohan Journal: PLoS One Date: 2012-11-07 Impact factor: 3.240